EMDB-29330:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-29333:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-29334:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-29335:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-43191:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 14 from N332-GT2 nanoparticle-immunized BG18HCgl knock-in mice
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-43192:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 15 from N332-GT5 nanoparticle-immunized BG18HCgl knock-in mice
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB

EMDB-28937:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from protein immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-28938:
N332-GT5 SOSIP in complex with V1V3 and base polyclonal Fabs isolated at day 16 from protein immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-28939:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized wild type mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-28940:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized BG18HCgl knock-in mice
Method: single particle / : Torres JL, Jackson AM, Ozorowski G, Ward AB

EMDB-28941:
HIV Env BG505_MD39_B11 SOSIP boosting trimer in complex with B11_d77.7 mouse Fab and RM20A3 Fab
Method: single particle / : Torres JL, Ozorowski G, Ward AB

EMDB-28942:
HIV Env germline targeting BG505_MD64_N332-GT5 SOSIP in complex with V3-glycan polyclonal Fab isolated from immunized BG18HCgl knock-in mice
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-28945:
HIV Env germline targeting BG505_MD64_N332-GT5 SOSIP in complex with V3-glycan polyclonal Fab isolated from immunized wild type mice, and NHP monoclonal Fab RM20A3
Method: single particle / : Ozorowski G, Ward AB

EMDB-43190:
HIV Env BG505_MD39_B16 SOSIP boosting trimer in complex with B16_d77.5 mouse Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41024:
MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41025:
MD65 N332-GT5 SOSIP in complex with RM_N332_36 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41026:
MD65 N332-GT5 SOSIP in complex with RM_N332_32 Fab and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41027:
MD65 N332-GT5 SOSIP in complex with RM_N332_08 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41034:
MD64 N332-GT5 SOSIP
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-41035:
MD65 N332-GT5 SOSIP in complex with RM_N332_07 Fab and RM20A3 Fab
Method: single particle / : Ozorowski G, Torres JL, Ward AB

EMDB-29530:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-29531:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-40240:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-28092:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-093
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28090:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-040
Method: single particle / : Li H, Callaway H, Yu X, Shek J, Saphire EO

EMDB-28091:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-045
Method: single particle / : Li H, Callaway H, Yu X, Shek J, Saphire EO

EMDB-28093:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-156
Method: single particle / : Shek J, Callaway H, Li H, Yu X, Saphire EO

EMDB-28094:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-234
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28095:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-260
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28096:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-279
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28097:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-290
Method: single particle / : Yu X, Callaway H, Li H, Shek J, Saphire EO

EMDB-28098:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-294
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28099:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-295
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28100:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-299
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28102:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-334
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28103:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-360
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28104:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-361
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28105:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-362
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28106:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-368
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28168:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-292
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28169:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-333
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28170:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-355
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-28171:
Negative stain EM map of SARS-CoV-2 Spike in complex with CoVIC-371
Method: single particle / : Callaway H, Li H, Yu X, Shek J, Saphire EO

EMDB-32490:
SARS-CoV-2 spike glycoprotein trimer in closed state
Method: single particle / : Zhu Y, Tai L, Yin G, Sun F

EMDB-32491:
SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L
Method: single particle / : Zhu Y, Tai L, Yin G, Sun F

EMDB-32492:
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
Method: single particle / : Zhu Y, Tai L, Yin G, Sun F

EMDB-32493:
SARS-CoV-2 spike glycoprotein trimer in open state
Method: single particle / : Zhu Y, Tai L, Yin G, Sun F

EMDB-27898:
Cryo-EM structure of human glycerol-3-phosphate acyltransferase 1 (GPAT1) in complex with 2-oxohexadecyl-CoA
Method: single particle / : Johnson ZL, Wasilko DJ, Ammirati M, Chang JS, Han S, Wu H

EMDB-27899:
Cryo-EM structure of human glycerol-3-phosphate acyltransferase 1 (GPAT1) in complex with CoA and palmitoyl-LPA
Method: single particle / : Wasilko DJ, Johnson ZL, Ammirati M, Chang JS, Han S, Wu H